Brokerages Set U.S. Physical Therapy, Inc. (NYSE:USPH) Target Price at $110.25

Key Points

• Analysts have assigned U.S. Physical Therapy, Inc. (NYSE: USPH) an average recommendation of "Moderate Buy", with a target price of $110.25.
• The company recently reported quarterly earnings with an EPS of $0.81, beating the consensus estimate of $0.71, and a revenue growth of 18.0% year-over-year.
• U.S. Physical Therapy has announced a quarterly dividend of $0.45, resulting in an annualized dividend yield of 2.2%.

U.S. Physical Therapy, Inc. (NYSE:USPH - Get Free Report) has received an average recommendation of "Moderate Buy" from the seven analysts that are currently covering the stock, MarketBeat.com reports. Two research analysts have rated the stock with a hold rating, four have given a buy rating and one has given a strong buy rating to the company. The average 12-month target price among brokers that have issued ratings on the stock in the last year is $110.25.

USPH has been the subject of a number of recent analyst reports. JPMorgan Chase & Co. initiated coverage on shares of U.S. Physical Therapy in a research note on Thursday. They set an "overweight" rating and a $110.00 price target for the company. Wall Street Zen cut shares of U.S. Physical Therapy from a "buy" rating to a "hold" rating in a research report on Sunday. Zacks Research raised shares of U.S. Physical Therapy to a "hold" rating in a research report on Friday, August 8th. Finally, Barrington Research boosted their price objective on shares of U.S. Physical Therapy from $98.00 to $103.00 and gave the company an "outperform" rating in a research report on Friday, August 8th.

Insider Buying and Selling

In other U.S. Physical Therapy news, COO Eric Joseph Williams sold 1,000 shares of the business's stock in a transaction dated Friday, September 5th. The shares were sold at an average price of $85.25, for a total value of $85,250.00. Following the completion of the sale, the chief operating officer directly owned 25,331 shares of the company's stock, valued at $2,159,467.75. The trade was a 3.80% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CFO Carey P. Hendrickson sold 698 shares of the business's stock in a transaction dated Monday, August 25th. The shares were sold at an average price of $86.11, for a total transaction of $60,104.78. Following the completion of the sale, the chief financial officer directly owned 27,808 shares of the company's stock, valued at approximately $2,394,546.88. This trade represents a 2.45% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 6,853 shares of company stock worth $581,406 over the last 90 days. Corporate insiders own 2.00% of the company's stock.

Institutional Investors Weigh In On U.S. Physical Therapy

Several large investors have recently modified their holdings of the business. Copeland Capital Management LLC raised its holdings in shares of U.S. Physical Therapy by 8.9% in the 2nd quarter. Copeland Capital Management LLC now owns 888,735 shares of the company's stock valued at $69,499,000 after purchasing an additional 72,463 shares in the last quarter. Geode Capital Management LLC raised its holdings in shares of U.S. Physical Therapy by 1.2% in the 2nd quarter. Geode Capital Management LLC now owns 352,923 shares of the company's stock valued at $27,602,000 after purchasing an additional 4,306 shares in the last quarter. Envestnet Asset Management Inc. raised its holdings in shares of U.S. Physical Therapy by 9.4% in the 2nd quarter. Envestnet Asset Management Inc. now owns 346,160 shares of the company's stock valued at $27,070,000 after purchasing an additional 29,671 shares in the last quarter. Bahl & Gaynor Inc. raised its holdings in shares of U.S. Physical Therapy by 32.6% in the 1st quarter. Bahl & Gaynor Inc. now owns 345,003 shares of the company's stock valued at $24,964,000 after purchasing an additional 84,878 shares in the last quarter. Finally, GW&K Investment Management LLC raised its holdings in shares of U.S. Physical Therapy by 8.9% in the 1st quarter. GW&K Investment Management LLC now owns 344,390 shares of the company's stock valued at $24,920,000 after purchasing an additional 28,203 shares in the last quarter.

U.S. Physical Therapy Trading Up 1.6%

Shares of USPH stock traded up $1.26 during trading hours on Friday, reaching $79.74. 114,786 shares of the stock were exchanged, compared to its average volume of 118,892. U.S. Physical Therapy has a 12-month low of $62.77 and a 12-month high of $101.19. The company has a current ratio of 1.18, a quick ratio of 1.18 and a debt-to-equity ratio of 0.30. The company's 50-day moving average price is $80.33 and its 200-day moving average price is $76.39. The firm has a market capitalization of $1.21 billion, a price-to-earnings ratio of 34.82, a price-to-earnings-growth ratio of 3.93 and a beta of 1.47.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last released its quarterly earnings results on Wednesday, August 6th. The company reported $0.81 EPS for the quarter, topping analysts' consensus estimates of $0.71 by $0.10. U.S. Physical Therapy had a net margin of 5.05% and a return on equity of 8.78%. The firm had revenue of $197.34 million during the quarter, compared to analysts' expectations of $190.24 million. During the same period in the previous year, the company earned $0.73 EPS. The firm's revenue for the quarter was up 18.0% compared to the same quarter last year. As a group, equities analysts anticipate that U.S. Physical Therapy will post 2.67 earnings per share for the current year.

U.S. Physical Therapy Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, September 12th. Shareholders of record on Friday, August 22nd were given a $0.45 dividend. This represents a $1.80 annualized dividend and a yield of 2.3%. The ex-dividend date of this dividend was Friday, August 22nd. U.S. Physical Therapy's payout ratio is 78.60%.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.